Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
JAMA|August 28, 2023
Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation: A Randomized Clinical TrialStephen J Nicholls, Steven E Nissen, Cynthia Fleming, et al.
The Journal of Biological Chemistry|October 27, 2006
Farnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulationTonghuan Hu, Michael Chouinard, Amy L Cox, et al.
Endocrinology|August 27, 2005
Hepatic peroxisomal fatty acid beta-oxidation is regulated by liver X receptor alphaTonghuan Hu, Patricia Foxworthy, Angela Siesky, et al.
Journal of the American College of Cardiology|March 30, 2025
Effect of ANGPTL3 Inhibition With Solbinsiran in Preclinical and Early Human StudiesKausik K Ray, Helle Linnebjerg, Laura F Michael, et al.
Frontiers in Cardiovascular Medicine|June 23, 2022
Influence of the Human Lipidome on Epicardial Fat Volume in Mexican American IndividualsAna Cristina Leandro, Laura F Michael, Marcio Almeida, et al.
Nature|August 16, 2002
Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibresJiandie Lin, Hai Wu, Paul T Tarr, et al.
The Journal of Biological Chemistry|November 21, 2002
A chemical switch regulates fibrate specificity for peroxisome proliferator-activated receptor alpha (PPARalpha ) versus liver X receptorJeffrey Thomas, Kelli S Bramlett, Chahrzad Montrose, et al.
Journal of Lipid Research|December 8, 2024
Measuring Lp(a) particles with a novel isoform-insensitive immunoassay illustrates efficacy of muvalaplinCraig A Swearingen, John H Sloan, Grace M Rhodes, et al.
Pageof 3